(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -0.54% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.15%.
Pfizer's revenue in 2025 is $62,785,000,000.On average, 23 Wall Street analysts forecast PFE's revenue for 2025 to be $361,082,229,504,864, with the lowest PFE revenue forecast at $342,165,880,479,360, and the highest PFE revenue forecast at $382,216,004,475,648. On average, 23 Wall Street analysts forecast PFE's revenue for 2026 to be $358,620,318,134,848, with the lowest PFE revenue forecast at $325,438,528,861,376, and the highest PFE revenue forecast at $386,292,656,790,432.
In 2027, PFE is forecast to generate $350,154,299,589,920 in revenue, with the lowest revenue forecast at $313,680,485,643,840 and the highest revenue forecast at $399,392,526,990,240.